Tom Spurling – Executive Director – Nova Eye Medical (ASX:EYE) is introducing a comprehensive portfolio of novel glaucoma treatment options which span the entire disease process – enabling physicians to intervene earlier, and more often, in the treatment of glaucoma.
Copyright 2023 – Finance News Network
Source: Finance News Network
13 Sep 2019 - Healthia Limited (ASX:HLA) Group CEO & Managing Director, Wesley Coote and Chairman, Dr Glen Richards talk about the company's FY19 results and its model of acquiring podiatry and physiotherapy clinics.
Read More08 Nov 2023 - Anax Metals (ASX:ANX) CEO, Geoff Laing, discusses the company's flagship Whim Creek Copper Hub, emphasizing its innovative approach and rapid path to production. The conversation delves into scalability, lithium exploration potential, and strategic partnerships, offering insights into Anax Metals' ambitious vision for resource development and polymetallic ventures.
Read More24 Nov 2020 - Mitchell Services Limited (ASX:MSV) CEO Andrew Elf provides an update on the company's FY20 results, its strategy of becoming Australia’s leading drilling services provider and the robust state of the mining sector.
Read More27 Feb 2020 - Ingenia Communities Group Limited (ASX:INA) CFO, Scott Noble, discusses 1H20 results, the company's portfolio and the demand for seniors accommodation.
Read More02 Jun 2022 - BluGlass Limited (ASX:BLG) Executive Chair James Walker provides an update on the company, discussing new staff and developments at BluGlass' manufacturing facility in Silicon Valley.
Read More01 Jul 2021 - Nyrada Limited (ASX:NYR) CEO James Bonnar discusses results from the company's study of its NYX-PCSK9i cholesterol-lowering compound.
Read More08 Aug 2023 - WT Financial Group Limited (ASX:WTL) Managing Director Keith Cullen discusses drivers of profitability, the effect of lower adviser numbers in the industry and opportunities moving forward.
Read More30 Mar 2022 - Immutep Limited (ASX:IMM) Executive Director and CEO Marc Voigt discusses encouraging results in second-line non-small cell lung cancer.
Read More23 Sep 2020 - Clayton Utz Partner Brendan Bateman discusses climate change risks, the legal duties of directors and how to factor such risks into financial valuations.
Read More24 Nov 2020 - SUDA Pharmaceuticals Limited (ASX:SUD) Managing Director Dr Michael Baker discusses the company's technology to convert solid dose drugs into oral sprays and the outlook for the year ahead.
Read More
